Patents by Inventor Guoqiang Wang

Guoqiang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Handling Consumer Mobility in Information-Centric Networks
    Publication number: 20170034055
    Abstract: Computer-implemented methods, computer software, and computer systems for handling consumer mobility in an information-centric networks (ICN). A pending interest table (PIT) including one or more PIT entries is maintained by an attachment point (AP) of a user equipment (UE) in the ICN. Each PIT entry identifies unsatisfied data requested by the UE. The data requested by the UE are specified in one or more interest packets that were previously received by the AP. An interest packet is received at the AP. The interest packet includes an identifier (ID) of a UE and a name of data that the UE requests. A PIT entry is identified by the AP. The PIT entry includes the name of the data requested by the UE in the interest packet. An index mapping the UE to the PIT entry is generated by the AP based on the ID of the UE.
    Type: Application
    Filed: July 28, 2015
    Publication date: February 2, 2017
    Inventors: Ravishankar Ravindran, Guoqiang Wang, Asit Chakraborti
  • Graphical Specification and Constraint Language for Developing Programs for Hardware Implementation and Use
    Publication number: 20160350080
    Abstract: Techniques for specifying and implementing programs. A graphical program is created in a graphical specification and constraint language that allows specification of a model of computation and explicit declaration of constraints in response to user input. The graphical program includes a specified model of computation, a plurality of interconnected functional blocks that visually indicate functionality of the graphical program in accordance with the specified model of computation, and specifications or constraints for the graphical program or at least one of the functional blocks in the graphical program. The specified model of computation and specifications or constraints are useable to analyze the graphical program or generate a program or simulation.
    Type: Application
    Filed: August 9, 2016
    Publication date: December 1, 2016
    Inventors: Kaushik Ravindran, Jacob Kornerup, Rhishikesh Limaye, Guang Yang, Guoqiang Wang, Jeffrey N. Correll, Arkadeb Ghosal, Sadia B. Malik, Charles E. Crain, II, Michael J. Trimborn
  • Macrocyclic hepatitis C serine protease inhibitors
    Patent number: 9493506
    Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: November 15, 2016
    Assignees: AbbVie Inc., Enata Pharmacueticals, Inc.
    Inventors: Hui-Ju Chen, Keith F. McDaniel, Brian E. Green, Jason P. Shanley, Albert W. Kruger, Jorge Gandarilla, Dennie S. Welch, Russell D. Cink, Steven C. Cullen, Yonghua Gai, Guoqiang Wang, Yat Sun Or
  • BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160289262
    Abstract: The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.
    Type: Application
    Filed: March 30, 2016
    Publication date: October 6, 2016
    Inventors: Guoqiang Wang, Yat Sun Or, Ruichao Shen, Xuechao Xing, Jiang Long, Peng Dai, Brett Granger, Jing He
  • Graphical specification and constraint language for developing programs for hardware implementation and use
    Patent number: 9436438
    Abstract: System and method for specifying and implementing programs. A graphical program is created in a graphical specification and constraint language that allows specification of a model of computation and explicit declaration of constraints in response to user input. The graphical program includes a specified model of computation, a plurality of interconnected functional blocks that visually indicate functionality of the graphical program in accordance with the specified model of computation, and specifications or constraints for the graphical program or at least one of the functional blocks in the graphical program. The specified model of computation and specifications or constraints are useable to analyze the graphical program or generate a program or simulation.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: September 6, 2016
    Assignee: NATIONAL INSTRUMENTS CORPORATION
    Inventors: Kaushik Ravindran, Jacob Kornerup, Rhishikesh Limaye, Guang Yang, Guoqiang Wang, Jeffrey N. Correll, Arkadeb Ghosal, Sadia B. Malik, Charles E. Crain, II, Michael J. Trimborn
  • BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160229886
    Abstract: The present invention provides compounds of Formula I: pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated by FXR and/or TGR5.
    Type: Application
    Filed: February 11, 2016
    Publication date: August 11, 2016
    Inventors: Ruichao Shen, Yat Sun Or, Guoqiang Wang
  • BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160185815
    Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
    Type: Application
    Filed: November 25, 2015
    Publication date: June 30, 2016
    Inventors: Guoqiang Wang, Yat Sun Or, Ruichao Shen, Jiang Long, Peng Dai, Xuechao Xing, Jing He
  • Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
    Publication number: 20160176917
    Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
    Type: Application
    Filed: December 21, 2015
    Publication date: June 23, 2016
    Inventors: Guoqiang Wang, Yat Sun Or, Ruichao Shen, Jiang Long, Peng Dai, Xuechao Xing, Jing He
  • MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
    Publication number: 20160145298
    Abstract: The present invention discloses compounds of Formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Application
    Filed: November 20, 2015
    Publication date: May 26, 2016
    Inventors: YAT SUN OR, Jun Ma, Guoqiang Wang, Jiang Long, Bin Wang
  • TETRAZOLE DERIVATIVES OF BILE ACIDS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160145295
    Abstract: The present invention provides compounds of Formula I: pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated by FXR and/or TGR5.
    Type: Application
    Filed: November 25, 2015
    Publication date: May 26, 2016
    Inventors: Yat Sun Or, Jin He, Guoqiang Wang
  • BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160145296
    Abstract: The present invention relates to compounds of Formula (IA) and Formula (IB), and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4, R5, R6, R7, R8, R9 and m are as defined herein, pharmaceutical compositions comprising these compounds and methods of use of these compounds for treating a TGR5 mediated disease or condition.
    Type: Application
    Filed: November 25, 2015
    Publication date: May 26, 2016
    Inventors: Yat Sun Or, Ruichao Shen, Peng Dai, Jiang Long, Xuechao Xing, Guoqiang Wang
  • NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION
    Publication number: 20160136233
    Abstract: The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
    Type: Application
    Filed: November 23, 2015
    Publication date: May 19, 2016
    Inventors: Yat Sun Or, Guoqiang Wang, Jiang Long, In Jong Kim
  • DEUTERATED NUCLEOSIDE/TIDE DERIVATIVES
    Publication number: 20160130294
    Abstract: The present invention provides nucleoside phosphoramidate compounds of Formula I, where R1, R2a, R2b, R4, R5a, R5b, Rb5, Rb6 and D are as defined herein. The invention further includes pharmaceutical compositions comprising a compound of Formula I, methods of use of these compounds for treating a viral infection, and methods of producing these compounds.
    Type: Application
    Filed: November 5, 2015
    Publication date: May 12, 2016
    Inventors: Jay R. Luly, Bin Wang, Guoqiang Wang, Yat Sun Or
  • BILE ACID ANALOGS AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
    Publication number: 20160130297
    Abstract: The present invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4, R5, R6, R7, R8 and m are as defined herein, pharmaceutical compositions comprising these compounds and methods of use of these compounds for treating a TGR5 mediated disease or condition.
    Type: Application
    Filed: November 5, 2015
    Publication date: May 12, 2016
    Inventors: Yat Sun Or, Guoqiang Wang, Ruichao Shen, Xuechao Xing
  • NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION
    Publication number: 20160130304
    Abstract: The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
    Type: Application
    Filed: November 3, 2015
    Publication date: May 12, 2016
    Inventors: Guoqiang Wang, In Jong Kim, Yat Sun Or
  • Optimization of a data flow program based on access pattern information
    Patent number: 9335977
    Abstract: System and method for optimizing a data flow diagram based on access pattern information are described. Access pattern information for a data flow diagram may be received. The data flow diagram may include a plurality of interconnected actors, e.g., functional blocks, visually indicating functionality of the data flow diagram. The access pattern information may include one or more of: input pattern information specifying cycles on which tokens are consumed by at least one of the actors, or output pattern information specifying cycles on which tokens are produced by at least one of the actors. A program that implements the functionality of the data flow diagram may be generated based at least in part on the access pattern information.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: May 10, 2016
    Assignee: National Instruments Corporation
    Inventors: Guoqiang Wang, Kaushik Ravindran, Rhishikesh Limaye, Guang Yang, Arkadeb Ghosal, Hugo A. Andrade, John R. Allen, Jacob Kornerup, Ian C. Wong, Jeffrey N. Correll, Michael J. Trimborn
  • Mapping Scheme Employed in an Information Centric Network to Manage Domain-Based Security and Mobility
    Publication number: 20160119837
    Abstract: A networking system comprising a virtual group controller in an information centric network configured to enable mobility and security for a plurality of users groups of the information centric network, a plurality of user groups coupled to the virtual group controller and associated with the users, a plurality of agents that are each associated with one of the user groups, and a database for trusted service profile coupled to the virtual group controller, wherein the virtual group controller is configured to interact with the agents to enable mobility for the user groups using a server-less domain-based naming scheme.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 28, 2016
    Inventors: Guoqiang Wang, Xinwen Zhang, Ravishankar Ravindran
  • DATA DISTRIBUTING OVER NETWORK TO USER DEVICES
    Publication number: 20160105279
    Abstract: A data device controls distribution of data to user devices through an edge router via an encryption scheme. The data device encrypts data using a first key and a public key, and sends the data to the edge router. The edge router encrypts the encrypted data with a second key and sends the re-encrypted data to a user device. The data device then authenticates the user device and issues a decryption key derived from a private key corresponding to the public key, the first key, and the second key to the user device. The user device uses the decryption key to decrypt and access the data.
    Type: Application
    Filed: October 12, 2015
    Publication date: April 14, 2016
    Applicant: Futurewei Technologies, Inc.
    Inventors: Qingji ZHENG, Guoqiang WANG, Ravishankar RAVINDRAN
  • METHOD AND APPARATUS FOR INTERFACE CAPABILITY AND ELASTIC CONTENT RESPONSE ENCODING IN INFORMATION CENTRIC NETWORKING
    Publication number: 20160094439
    Abstract: A method for state based forwarding using an embedded flag in the type length values (TLV) architecture of information centric network (ICN) interfaces, the method comprises storing, in static and dynamic fashions forward information for ICN router interfaces, the stored information is stored in a pending interest table (PIT) table associated with the ICN router interface. Next, using, a flag within the stored information in the TLV architecture of the ICN router interface wherein the flag is associated with an interest capability of the ICN router interface. Further, receiving, an interest associated with flag for forwarding at the ICN router interface, and checking, the received interest with the stored information in the PIT table of the ICN router interface for forwarding to a content source.
    Type: Application
    Filed: September 1, 2015
    Publication date: March 31, 2016
    Inventors: Ravishankar Ravindran, Guoqiang Wang, Asit Chakraborti, Aytac AZGIN
  • CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION
    Publication number: 20160051625
    Abstract: The present invention relates to cyclosporin analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporin analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
    Type: Application
    Filed: September 2, 2015
    Publication date: February 25, 2016
    Inventors: Yat Sun Or, Guoqiang Wang, Jiang Long, Xuri Gao